{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:41:54Z","timestamp":1777992114773,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T00:00:00Z","timestamp":1507939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00134-017-4962-2","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T00:51:11Z","timestamp":1507942271000},"page":"73-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["When antibiotic treatment fails"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-962X","authenticated-orcid":false,"given":"Matteo","family":"Bassetti","sequence":"first","affiliation":[]},{"given":"Jos\u00e8 Garnacho","family":"Montero","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Artur","family":"Paiva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,14]]},"reference":[{"issue":"6","key":"4962_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/IPC.0000000000000225","volume":"22","author":"GH Talbot","year":"2014","unstructured":"Talbot GH (2014) The early response end point in clinical trials not just for FDA anymore? Infect Dis Clin Pract 22(6):307\u2013308","journal-title":"Infect Dis Clin Pract"},{"issue":"S14","key":"4962_CR2","first-page":"S19","volume":"34","author":"M Sanchez Garcia","year":"2009","unstructured":"Sanchez Garcia M (2009) Early antibiotic failure. Int J Antimicrob Agents 34(S14):S19","journal-title":"Int J Antimicrob Agents"},{"key":"4962_CR3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s00134-017-4802-4","volume":"43","author":"JF Timsit","year":"2017","unstructured":"Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E et al (2017) Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE\u2019s STAT-Net. Intensive Care Med 43:1002\u20131012","journal-title":"Intensive Care Med"},{"key":"4962_CR4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.CCM.0000055380.86458.1E","volume":"31","author":"CM Luna","year":"2003","unstructured":"Luna CM, Blanzaco D, Niederman MS et al (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676\u2013682","journal-title":"Crit Care Med"},{"key":"4962_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4878-x","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A (2017) Antimicrobial resistance in the next 30\u00a0years, humankind, bugs and drugs: a visionary approach. Intensive Care Med. doi:\n                        10.1007\/s00134-017-4878-x","journal-title":"Intensive Care Med"},{"key":"4962_CR6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cis566","volume":"55","author":"GH Talbot","year":"2012","unstructured":"Talbot GH, Powers JH, Fleming TR, Siuciak JA, Bradley J, Boucher H (2012) Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health. Clin Infect Dis 55:1114\u20131121","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4962_CR7","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/cc10072","volume":"15","author":"MK Joung","year":"2011","unstructured":"Joung MK, Lee JA et al (2011) Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 15(2):R79","journal-title":"Crit Care"},{"key":"4962_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A et al (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32\u201340","journal-title":"Intensive Care Med"},{"key":"4962_CR9","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/cc5036","volume":"10","author":"R Seligman","year":"2006","unstructured":"Seligman R, Meisner M, Lisboa TC et al (2006) Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 10:R125","journal-title":"Crit Care"},{"key":"4962_CR10","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","volume":"39","author":"JU Jensen","year":"2011","unstructured":"Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39:2048\u20132058. doi:\n                        10.1097\/CCM.0b013e31821e8791","journal-title":"Crit Care Med"},{"key":"4962_CR11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2007.086785","volume":"63","author":"R Menendez","year":"2008","unstructured":"Menendez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos M et al (2008) Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63:447\u2013452","journal-title":"Thorax"},{"issue":"1","key":"4962_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2049936112469017","volume":"1","author":"J Gon\u00e7alves-Pereira","year":"2013","unstructured":"Gon\u00e7alves-Pereira J, Concei\u00e7ao C, P\u00f3voa P (2013) Community-acquired pneumonia: identification and evaluation of nonresponders. Ther Adv Infect Dis 1(1):5\u201317","journal-title":"Ther Adv Infect Dis"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-4962-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4962-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T12:43:06Z","timestamp":1516279386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-4962-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,14]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4962"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-4962-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,14]]}}}